🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the comparative bioavailability ...
Status
Terminated
Location
California Clinical Trials
Start Date
2010-01
Trial ID
NCT01046214
Treatments Being Tested
The primary objective of this study is to evaluate the impact of substance-...
Status
Completed
Location
La Frontera
Start Date
2010-02
Trial ID
NCT01077024
Treatments Being Tested
Determine bioequivalence between branded and generic bupropion extended rel...
Status
Completed
Location
Washington University School of Medicine
Start Date
2014-06-25
Trial ID
NCT02209597
Treatments Being Tested
The purpose of this study is to demonstrate the relative bioequivalence of ...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00861939
This study will utilize a randomized double-blind design to evaluate whethe...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2007-08
Trial ID
NCT00519428
Treatments Being Tested
The present proposal is an innovative and translational clinical trial deri...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2017-09-04
Trial ID
NCT03169244
Treatments Being Tested
The main purpose of this study is to correlate brain testing with treatment...
Status
Completed
Location
Depression Evaluation Service - New York State Psychiatric Institute
Start Date
2004-12
Trial ID
NCT00296777
Treatments Being Tested
This phase II randomized trial studies how well bupropion hydrochloride wor...
Status
Completed
Location
Kaiser Permanente-Anaheim
Start Date
2017-05-31
Trial ID
NCT03180294
Treatments Being Tested
Smoking cessation has been shown to improve the effectiveness and reduce th...
Status
Completed
Location
Med Center Health
Start Date
2021-01-12
Trial ID
NCT04634071
This is an open-label Phase IIa pilot study of the tolerability and effects...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2016-11-01
Trial ID
NCT02842073
Treatments Being Tested